Personal information

No personal information available

Biography

Drug analysis, chromatography, method development, method validation, quality control are my research interest.

Activities

Collapse all

Education and qualifications (2)

Tehran University of Medical Sciences: Tehran, IR

2018-10-03 to 2024-07-30 | PhD (Drug and Food Control)
Education
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Shahid Sadoughi  University of Medical Sciences and Health Services: Yazd, Yazd, IR

2011-09-23 to 2018-09-22 | doctorate (pharmacy)
Education
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Professional activities (2)

Shahid Sadoughi University of Medical Sciences and Health Services: Yazd, IR

2023-10-01 to 2025-01-30 | Teaching (Pharmaceutics)
Membership
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Tehran University of Medical Sciences: Tehran, IR

2022-10-01 to 2022-11-30 | Teaching (Drug and Food Control)
Membership
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Works (8)

A GC–MS Method for Determination of β-Propiolactone Residues in Inactivated Covid-19 Vaccines

Journal of Chromatographic Science
2024-12-11 | Journal article
DOI: 10.1093/chromsci/bmae049
Part of ISSN: 0021-9665
Part of ISSN: 1945-239X
Contributors: Seyedeh Zohreh Mirjalili; Zahra Tamiji; Mehrnoosh Shirangi; Mohsen Amini
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Development of a high-performance liquid chromatography using rhodamine B hydrazide as the derivatization reagent for determination of β propiolactone residues in inactivated COVID-19 vaccines

Journal of Chromatography B
2024-08 | Journal article
DOI: 10.1016/j.jchromb.2024.124241
Part of ISSN: 1570-0232
Contributors: Seyedeh Zohreh Mirjalili; Fatemeh Chavoshi; Mohsen Amini; ZahraTamiji; Farzad Kobarfard; Mehrnoosh Shirangi
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Forced Degradation Products of Liraglutide: A Comparative Study of Similarity Between Originator and Analogue Version by Liquid Chromatography–Mass Spectrometry

International Journal of Peptide Research and Therapeutics
2024-04-24 | Journal article
DOI: 10.1007/s10989-024-10608-8
Part of ISSN: 1573-3904
Contributors: Fatemeh Chavoshi; Seyedeh Zohreh Mirjalili; Ali Mohammadi; Mohsen Amini; Govert W. Somsen; Mehrnoosh Shirangi
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Efficacy and safety of immune checkpoint inhibitors and cytokine therapy in autoimmune diseases

Translational Autoimmunity
2022 | Book chapter
DOI: 10.1016/b978-0-12-824390-9.00011-6
Part of ISBN: 9780128243909
Contributors: Reyhaneh Sabourian; Seyedeh Zohreh Mirjalili; Nima Rezaei
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disorders

International Immunopharmacology
2021-12 | Journal article
DOI: 10.1016/j.intimp.2021.108305
Part of ISSN: 1567-5769
Contributors: Seyedeh Zohreh Mirjalili; Reyhaneh Sabourian; Mona Sadeghalvad; Nima Rezaei
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

HPLC methods for quantifying anticancer drugs in human samples: A systematic review

Analytical Biochemistry
2020-12 | Journal article
DOI: 10.1016/j.ab.2020.113891
Part of ISSN: 0003-2697
Contributors: Reyhaneh Sabourian; Seyedeh Zohreh Mirjalili; Negar Namini; Fateme Chavoshy; Mannan Hajimahmoodi; Maliheh Safavi
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Comparison of The Effect of Breads Containing Milled Sesame or Flaxseed on Blood Pressure of Patient in Stage I Hypertension

Journal of Shahid Sadoughi University of Medical Sciences
2020-12-21 | Journal article
DOI: 10.18502/ssu.v28i10.4925
Part of ISSN: 2228-5733
Part of ISSN: 2228-5741
Contributors: Moneyreh Modarres Mosadegh; Mozhgan Modarresi; Seyedeh Mahdieh Nemayandeh; Masoud Mirzaei; Mahdieh Jabinzadeh; Sheida Shahedipour; Zohreh Mirjalili; Zeinab Najari; Azadeh Najarzadeh
Source: Self-asserted source
Seyedeh Zohreh Mirjalili

Design, synthesis, molecular docking study and biological evaluation of heteroaryl 2-phenoxypyridin-3-yl derivatives as lipoxygenase enzyme inhibitors

2018-10-15 | Journal article
Contributors: Seyedeh Zohreh Mirjalili
Source: Self-asserted source
Seyedeh Zohreh Mirjalili
How many people are using ORCID?